世界の自動・閉鎖型細胞調整システム市場インサイト及び予測(幹細胞治療、非幹細胞治療)

◆英語タイトル:Global Automated And Closed Cell Therapy Processing Systems Market Insights, Forecast to 2028

QYResearchが発行した調査報告書(QY22JLX09229)◆商品コード:QY22JLX09229
◆発行会社(リサーチ会社):QYResearch
◆発行日:2022年7月(※2025年版があります。お問い合わせください。)
◆ページ数:105
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,900 ⇒換算¥744,800見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD7,350 ⇒換算¥1,117,200見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD9,800 ⇒換算¥1,489,600見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

COVID-19のパンデミックにより、自動・閉鎖型細胞調整システムのグローバル市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx%で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に自動・閉鎖型細胞調整システムの世界市場のxxx%を占める「幹細胞治療」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx%CAGRで成長すると予測されています。一方、「プレコマーシャル/R&Dスケール」セグメントは、この予測期間を通じてxxx%のCAGRに変更されます。
自動・閉鎖型細胞調整システムの中国市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx%であり、中国とヨーロッパはそれぞれxxx%とxxx%です。中国の割合は2028年にxxx%に達し、対象期間を通じてxxx%のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx%、xxx%、xxx%になる見通しです。ヨーロッパの自動・閉鎖型細胞調整システム市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx%になる見通しです。

自動・閉鎖型細胞調整システムのグローバル主要企業には、MiltenyiBiotec、Lonza、Fresenius Kabi、Cytiva (Danaher Corp.)、BioSpherix, Ltd.、Terumo Corporation、Sartorius AG、ThermoGenesis Holdings, Inc.、Cellares Inc.、Thermo Fisher Scientific, Inc.などがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx%の市場シェアを占めています。

自動・閉鎖型細胞調整システム市場は、種類と用途によって区分されます。世界の自動・閉鎖型細胞調整システム市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年~2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
幹細胞治療、非幹細胞治療

【用途別セグメント】
プレコマーシャル/R&Dスケール、コマーシャルスケール

【掲載地域】
北米:アメリカ、カナダ
ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋:日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米:メキシコ、ブラジル、アルゼンチン
中東・アフリカ:トルコ、サウジアラビア、UAE

【目次(一部)】

・調査の範囲
- 自動・閉鎖型細胞調整システム製品概要
- 種類別市場(幹細胞治療、非幹細胞治療)
- 用途別市場(プレコマーシャル/R&Dスケール、コマーシャルスケール)
- 調査の目的
・エグゼクティブサマリー
- 世界の自動・閉鎖型細胞調整システム販売量予測2017-2028
- 世界の自動・閉鎖型細胞調整システム売上予測2017-2028
- 自動・閉鎖型細胞調整システムの地域別販売量
- 自動・閉鎖型細胞調整システムの地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別自動・閉鎖型細胞調整システム販売量
- 主要メーカー別自動・閉鎖型細胞調整システム売上
- 主要メーカー別自動・閉鎖型細胞調整システム価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模(幹細胞治療、非幹細胞治療)
- 自動・閉鎖型細胞調整システムの種類別販売量
- 自動・閉鎖型細胞調整システムの種類別売上
- 自動・閉鎖型細胞調整システムの種類別価格
・用途別市場規模(プレコマーシャル/R&Dスケール、コマーシャルスケール)
- 自動・閉鎖型細胞調整システムの用途別販売量
- 自動・閉鎖型細胞調整システムの用途別売上
- 自動・閉鎖型細胞調整システムの用途別価格
・北米市場
- 北米の自動・閉鎖型細胞調整システム市場規模(種類別、用途別)
- 主要国別の自動・閉鎖型細胞調整システム市場規模(アメリカ、カナダ)
・ヨーロッパ市場
- ヨーロッパの自動・閉鎖型細胞調整システム市場規模(種類別、用途別)
- 主要国別の自動・閉鎖型細胞調整システム市場規模(ドイツ、フランス、イギリス、イタリア、ロシア)
・アジア太平洋市場
- アジア太平洋の自動・閉鎖型細胞調整システム市場規模(種類別、用途別)
- 主要国別の自動・閉鎖型細胞調整システム市場規模(日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア)
・中南米市場
- 中南米の自動・閉鎖型細胞調整システム市場規模(種類別、用途別)
- 主要国別の自動・閉鎖型細胞調整システム市場規模(メキシコ、ブラジル、アルゼンチン)
・中東・アフリカ市場
- 中東・アフリカの自動・閉鎖型細胞調整システム市場規模(種類別、用途別)
- 主要国別の自動・閉鎖型細胞調整システム市場規模(トルコ、サウジアラビア)
・企業情報
MiltenyiBiotec、Lonza、Fresenius Kabi、Cytiva (Danaher Corp.)、BioSpherix, Ltd.、Terumo Corporation、Sartorius AG、ThermoGenesis Holdings, Inc.、Cellares Inc.、Thermo Fisher Scientific, Inc.
・産業チェーン及び販売チャネル分析
- 自動・閉鎖型細胞調整システムの産業チェーン分析
- 自動・閉鎖型細胞調整システムの原材料
- 自動・閉鎖型細胞調整システムの生産プロセス
- 自動・閉鎖型細胞調整システムの販売及びマーケティング
- 自動・閉鎖型細胞調整システムの主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 自動・閉鎖型細胞調整システムの産業動向
- 自動・閉鎖型細胞調整システムのマーケットドライバー
- 自動・閉鎖型細胞調整システムの課題
- 自動・閉鎖型細胞調整システムの阻害要因
・主な調査結果

The growing popularity of regenerative medicines & cell therapies coupled with a range of benefits offered by automation technologies for the development of these therapies is expected to propel the market growth.
Market Analysis and Insights: Global Automated And Closed Cell Therapy Processing Systems Market
The global Automated And Closed Cell Therapy Processing Systems market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Stem Cell Therapy accounting for % of the Automated And Closed Cell Therapy Processing Systems global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Pre-commercial/R&D Scale segment is altered to an % CAGR throughout this forecast period.
China Automated And Closed Cell Therapy Processing Systems market size is valued at US$ million in 2021, while the North America and Europe Automated And Closed Cell Therapy Processing Systems are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Automated And Closed Cell Therapy Processing Systems landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Automated And Closed Cell Therapy Processing Systems market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Automated And Closed Cell Therapy Processing Systems market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Automated And Closed Cell Therapy Processing Systems market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Automated And Closed Cell Therapy Processing Systems market.
Global Automated And Closed Cell Therapy Processing Systems Scope and Market Size
Automated And Closed Cell Therapy Processing Systems market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Automated And Closed Cell Therapy Processing Systems market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Stem Cell Therapy
Non-Stem Cell Therapy
Segment by Application
Pre-commercial/R&D Scale
Commercial Scale
By Company
MiltenyiBiotec
Lonza
Fresenius Kabi
Cytiva (Danaher Corp.)
BioSpherix, Ltd.
Terumo Corporation
Sartorius AG
ThermoGenesis Holdings, Inc.
Cellares Inc.
Thermo Fisher Scientific, Inc.
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

❖ レポートの目次 ❖

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Automated And Closed Cell Therapy Processing Systems Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Stem Cell Therapy
1.2.3 Non-Stem Cell Therapy
1.3 Market by Application
1.3.1 Global Automated And Closed Cell Therapy Processing Systems Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Pre-commercial/R&D Scale
1.3.3 Commercial Scale
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Automated And Closed Cell Therapy Processing Systems Market Perspective (2017-2028)
2.2 Automated And Closed Cell Therapy Processing Systems Growth Trends by Region
2.2.1 Automated And Closed Cell Therapy Processing Systems Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Automated And Closed Cell Therapy Processing Systems Historic Market Size by Region (2017-2022)
2.2.3 Automated And Closed Cell Therapy Processing Systems Forecasted Market Size by Region (2023-2028)
2.3 Automated And Closed Cell Therapy Processing Systems Market Dynamics
2.3.1 Automated And Closed Cell Therapy Processing Systems Industry Trends
2.3.2 Automated And Closed Cell Therapy Processing Systems Market Drivers
2.3.3 Automated And Closed Cell Therapy Processing Systems Market Challenges
2.3.4 Automated And Closed Cell Therapy Processing Systems Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Automated And Closed Cell Therapy Processing Systems Players by Revenue
3.1.1 Global Top Automated And Closed Cell Therapy Processing Systems Players by Revenue (2017-2022)
3.1.2 Global Automated And Closed Cell Therapy Processing Systems Revenue Market Share by Players (2017-2022)
3.2 Global Automated And Closed Cell Therapy Processing Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Automated And Closed Cell Therapy Processing Systems Revenue
3.4 Global Automated And Closed Cell Therapy Processing Systems Market Concentration Ratio
3.4.1 Global Automated And Closed Cell Therapy Processing Systems Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Automated And Closed Cell Therapy Processing Systems Revenue in 2021
3.5 Automated And Closed Cell Therapy Processing Systems Key Players Head office and Area Served
3.6 Key Players Automated And Closed Cell Therapy Processing Systems Product Solution and Service
3.7 Date of Enter into Automated And Closed Cell Therapy Processing Systems Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Automated And Closed Cell Therapy Processing Systems Breakdown Data by Type
4.1 Global Automated And Closed Cell Therapy Processing Systems Historic Market Size by Type (2017-2022)
4.2 Global Automated And Closed Cell Therapy Processing Systems Forecasted Market Size by Type (2023-2028)
5 Automated And Closed Cell Therapy Processing Systems Breakdown Data by Application
5.1 Global Automated And Closed Cell Therapy Processing Systems Historic Market Size by Application (2017-2022)
5.2 Global Automated And Closed Cell Therapy Processing Systems Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Automated And Closed Cell Therapy Processing Systems Market Size (2017-2028)
6.2 North America Automated And Closed Cell Therapy Processing Systems Market Size by Type
6.2.1 North America Automated And Closed Cell Therapy Processing Systems Market Size by Type (2017-2022)
6.2.2 North America Automated And Closed Cell Therapy Processing Systems Market Size by Type (2023-2028)
6.2.3 North America Automated And Closed Cell Therapy Processing Systems Market Share by Type (2017-2028)
6.3 North America Automated And Closed Cell Therapy Processing Systems Market Size by Application
6.3.1 North America Automated And Closed Cell Therapy Processing Systems Market Size by Application (2017-2022)
6.3.2 North America Automated And Closed Cell Therapy Processing Systems Market Size by Application (2023-2028)
6.3.3 North America Automated And Closed Cell Therapy Processing Systems Market Share by Application (2017-2028)
6.4 North America Automated And Closed Cell Therapy Processing Systems Market Size by Country
6.4.1 North America Automated And Closed Cell Therapy Processing Systems Market Size by Country (2017-2022)
6.4.2 North America Automated And Closed Cell Therapy Processing Systems Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Automated And Closed Cell Therapy Processing Systems Market Size (2017-2028)
7.2 Europe Automated And Closed Cell Therapy Processing Systems Market Size by Type
7.2.1 Europe Automated And Closed Cell Therapy Processing Systems Market Size by Type (2017-2022)
7.2.2 Europe Automated And Closed Cell Therapy Processing Systems Market Size by Type (2023-2028)
7.2.3 Europe Automated And Closed Cell Therapy Processing Systems Market Share by Type (2017-2028)
7.3 Europe Automated And Closed Cell Therapy Processing Systems Market Size by Application
7.3.1 Europe Automated And Closed Cell Therapy Processing Systems Market Size by Application (2017-2022)
7.3.2 Europe Automated And Closed Cell Therapy Processing Systems Market Size by Application (2023-2028)
7.3.3 Europe Automated And Closed Cell Therapy Processing Systems Market Share by Application (2017-2028)
7.4 Europe Automated And Closed Cell Therapy Processing Systems Market Size by Country
7.4.1 Europe Automated And Closed Cell Therapy Processing Systems Market Size by Country (2017-2022)
7.4.2 Europe Automated And Closed Cell Therapy Processing Systems Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Automated And Closed Cell Therapy Processing Systems Market Size (2017-2028)
8.2 Asia-Pacific Automated And Closed Cell Therapy Processing Systems Market Size by Type
8.2.1 Asia-Pacific Automated And Closed Cell Therapy Processing Systems Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Automated And Closed Cell Therapy Processing Systems Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Automated And Closed Cell Therapy Processing Systems Market Share by Type (2017-2028)
8.3 Asia-Pacific Automated And Closed Cell Therapy Processing Systems Market Size by Application
8.3.1 Asia-Pacific Automated And Closed Cell Therapy Processing Systems Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Automated And Closed Cell Therapy Processing Systems Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Automated And Closed Cell Therapy Processing Systems Market Share by Application (2017-2028)
8.4 Asia-Pacific Automated And Closed Cell Therapy Processing Systems Market Size by Region
8.4.1 Asia-Pacific Automated And Closed Cell Therapy Processing Systems Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Automated And Closed Cell Therapy Processing Systems Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Automated And Closed Cell Therapy Processing Systems Market Size (2017-2028)
9.2 Latin America Automated And Closed Cell Therapy Processing Systems Market Size by Type
9.2.1 Latin America Automated And Closed Cell Therapy Processing Systems Market Size by Type (2017-2022)
9.2.2 Latin America Automated And Closed Cell Therapy Processing Systems Market Size by Type (2023-2028)
9.2.3 Latin America Automated And Closed Cell Therapy Processing Systems Market Share by Type (2017-2028)
9.3 Latin America Automated And Closed Cell Therapy Processing Systems Market Size by Application
9.3.1 Latin America Automated And Closed Cell Therapy Processing Systems Market Size by Application (2017-2022)
9.3.2 Latin America Automated And Closed Cell Therapy Processing Systems Market Size by Application (2023-2028)
9.3.3 Latin America Automated And Closed Cell Therapy Processing Systems Market Share by Application (2017-2028)
9.4 Latin America Automated And Closed Cell Therapy Processing Systems Market Size by Country
9.4.1 Latin America Automated And Closed Cell Therapy Processing Systems Market Size by Country (2017-2022)
9.4.2 Latin America Automated And Closed Cell Therapy Processing Systems Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Automated And Closed Cell Therapy Processing Systems Market Size (2017-2028)
10.2 Middle East & Africa Automated And Closed Cell Therapy Processing Systems Market Size by Type
10.2.1 Middle East & Africa Automated And Closed Cell Therapy Processing Systems Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Automated And Closed Cell Therapy Processing Systems Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Automated And Closed Cell Therapy Processing Systems Market Share by Type (2017-2028)
10.3 Middle East & Africa Automated And Closed Cell Therapy Processing Systems Market Size by Application
10.3.1 Middle East & Africa Automated And Closed Cell Therapy Processing Systems Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Automated And Closed Cell Therapy Processing Systems Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Automated And Closed Cell Therapy Processing Systems Market Share by Application (2017-2028)
10.4 Middle East & Africa Automated And Closed Cell Therapy Processing Systems Market Size by Country
10.4.1 Middle East & Africa Automated And Closed Cell Therapy Processing Systems Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Automated And Closed Cell Therapy Processing Systems Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 MiltenyiBiotec
11.1.1 MiltenyiBiotec Company Details
11.1.2 MiltenyiBiotec Business Overview
11.1.3 MiltenyiBiotec Automated And Closed Cell Therapy Processing Systems Introduction
11.1.4 MiltenyiBiotec Revenue in Automated And Closed Cell Therapy Processing Systems Business (2017-2022)
11.1.5 MiltenyiBiotec Recent Developments
11.2 Lonza
11.2.1 Lonza Company Details
11.2.2 Lonza Business Overview
11.2.3 Lonza Automated And Closed Cell Therapy Processing Systems Introduction
11.2.4 Lonza Revenue in Automated And Closed Cell Therapy Processing Systems Business (2017-2022)
11.2.5 Lonza Recent Developments
11.3 Fresenius Kabi
11.3.1 Fresenius Kabi Company Details
11.3.2 Fresenius Kabi Business Overview
11.3.3 Fresenius Kabi Automated And Closed Cell Therapy Processing Systems Introduction
11.3.4 Fresenius Kabi Revenue in Automated And Closed Cell Therapy Processing Systems Business (2017-2022)
11.3.5 Fresenius Kabi Recent Developments
11.4 Cytiva (Danaher Corp.)
11.4.1 Cytiva (Danaher Corp.) Company Details
11.4.2 Cytiva (Danaher Corp.) Business Overview
11.4.3 Cytiva (Danaher Corp.) Automated And Closed Cell Therapy Processing Systems Introduction
11.4.4 Cytiva (Danaher Corp.) Revenue in Automated And Closed Cell Therapy Processing Systems Business (2017-2022)
11.4.5 Cytiva (Danaher Corp.) Recent Developments
11.5 BioSpherix, Ltd.
11.5.1 BioSpherix, Ltd. Company Details
11.5.2 BioSpherix, Ltd. Business Overview
11.5.3 BioSpherix, Ltd. Automated And Closed Cell Therapy Processing Systems Introduction
11.5.4 BioSpherix, Ltd. Revenue in Automated And Closed Cell Therapy Processing Systems Business (2017-2022)
11.5.5 BioSpherix, Ltd. Recent Developments
11.6 Terumo Corporation
11.6.1 Terumo Corporation Company Details
11.6.2 Terumo Corporation Business Overview
11.6.3 Terumo Corporation Automated And Closed Cell Therapy Processing Systems Introduction
11.6.4 Terumo Corporation Revenue in Automated And Closed Cell Therapy Processing Systems Business (2017-2022)
11.6.5 Terumo Corporation Recent Developments
11.7 Sartorius AG
11.7.1 Sartorius AG Company Details
11.7.2 Sartorius AG Business Overview
11.7.3 Sartorius AG Automated And Closed Cell Therapy Processing Systems Introduction
11.7.4 Sartorius AG Revenue in Automated And Closed Cell Therapy Processing Systems Business (2017-2022)
11.7.5 Sartorius AG Recent Developments
11.8 ThermoGenesis Holdings, Inc.
11.8.1 ThermoGenesis Holdings, Inc. Company Details
11.8.2 ThermoGenesis Holdings, Inc. Business Overview
11.8.3 ThermoGenesis Holdings, Inc. Automated And Closed Cell Therapy Processing Systems Introduction
11.8.4 ThermoGenesis Holdings, Inc. Revenue in Automated And Closed Cell Therapy Processing Systems Business (2017-2022)
11.8.5 ThermoGenesis Holdings, Inc. Recent Developments
11.9 Cellares Inc.
11.9.1 Cellares Inc. Company Details
11.9.2 Cellares Inc. Business Overview
11.9.3 Cellares Inc. Automated And Closed Cell Therapy Processing Systems Introduction
11.9.4 Cellares Inc. Revenue in Automated And Closed Cell Therapy Processing Systems Business (2017-2022)
11.9.5 Cellares Inc. Recent Developments
11.10 Thermo Fisher Scientific, Inc.
11.10.1 Thermo Fisher Scientific, Inc. Company Details
11.10.2 Thermo Fisher Scientific, Inc. Business Overview
11.10.3 Thermo Fisher Scientific, Inc. Automated And Closed Cell Therapy Processing Systems Introduction
11.10.4 Thermo Fisher Scientific, Inc. Revenue in Automated And Closed Cell Therapy Processing Systems Business (2017-2022)
11.10.5 Thermo Fisher Scientific, Inc. Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の自動・閉鎖型細胞調整システム市場インサイト及び予測(幹細胞治療、非幹細胞治療)(Global Automated And Closed Cell Therapy Processing Systems Market Insights, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。